"description","uuid:ID","label","id","name","text","instanceType"
"Main objective","4ce04bae-8937-4513-9d15-70e8fdeeb04a","","Objective_1","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJECTIVE"
"Safety","b8fc8a08-2ef4-4f1d-b374-d96f3e715033","","Objective_2","OBJ2","To document the safety profile of the xanomeline TTS.","OBJECTIVE"
"Behaviour","b6377765-307e-48aa-b94c-a193b36c1214","","Objective_3","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJECTIVE"
